Implementing Age-Specific Safety Monitoring in Clinical Trials
Implementing Age-Specific Safety Monitoring in Clinical Trials Age-Specific Strategies for Safety Monitoring in Clinical Trials Why Safety Monitoring Must be Age-Specific Safety monitoring is one of the most critical aspects of clinical trial conduct, especially when involving vulnerable populations such as children and elderly adults. Physiological differences—such as immature metabolic pathways in neonates or reduced…
Read More “Implementing Age-Specific Safety Monitoring in Clinical Trials” »